These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21607350)

  • 1. Progress in radioimmunotherapy of head and neck-cancer (review).
    Vandongen G; Brakenhoff R; Debree R; Gerretsen M; Quak J; Snow G
    Oncol Rep; 1994 Jan; 1(1):259-64. PubMed ID: 21607350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.
    de Bree R; Roos JC; Plaizier MA; Quak JJ; van Kamp GJ; den Hollander W; Snow GB; van Dongen GA
    Br J Cancer; 1997; 75(7):1049-60. PubMed ID: 9083342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice.
    van Gog FB; Brakenhoff RH; Snow GB; van Dongen GA
    Cancer Immunol Immunother; 1997 Apr; 44(2):103-11. PubMed ID: 9177472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.
    Brakenhoff RH; van Gog FB; Looney JE; van Walsum M; Snow GB; van Dongen GA
    Cancer Immunol Immunother; 1995 Mar; 40(3):191-200. PubMed ID: 7728778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
    van Gog FB; Visser GW; Stroomer JW; Roos JC; Snow GB; van Dongen GA
    Cancer; 1997 Dec; 80(12 Suppl):2360-70. PubMed ID: 9406684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
    J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
    Börjesson PK; Postema EJ; Roos JC; Colnot DR; Marres HA; van Schie MH; Stehle G; de Bree R; Snow GB; Oyen WJ; van Dongen GA
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3961S-72S. PubMed ID: 14506195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.
    van Dongen GA; Brakenhoff RM; ten Brink CT; van Gog FB; de Bree R; Quak JJ; Snow GB
    Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
    Visser GW; Gerretsen M; Herscheid JD; Snow GB; van Dongen G
    J Nucl Med; 1993 Nov; 34(11):1953-63. PubMed ID: 8229241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.
    Gerretsen M; Visser GW; Brakenhoff RH; van Walsum M; Snow GB; van Dongen GA
    Cell Biophys; 1994; 24-25():135-42. PubMed ID: 7736517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients.
    de Bree R; Kuik DJ; Quak JJ; Roos JC; van den Brekel MW; Castelijns JA; van Wagtendonk FW; Greuter H; Snow GB; van Dongen GA
    Eur J Nucl Med; 1998 Nov; 25(11):1562-5. PubMed ID: 9799354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.
    Verel I; Visser GW; Vosjan MJ; Finn R; Boellaard R; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1645-52. PubMed ID: 15290121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
    Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
    J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of radioimmunotherapy of head and neck cancer.
    Gerretsen M; Quak JJ; Brakenhoff RH; Snow GB; van Dongen GA
    Eur J Cancer B Oral Oncol; 1994; 30B(2):82-7. PubMed ID: 8032305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.
    Folli S; Westermann P; Braichotte D; Pèlegrin A; Wagnières G; van den Bergh H; Mach JP
    Cancer Res; 1994 May; 54(10):2643-9. PubMed ID: 8168092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.
    Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
    Cancer Res; 2001 Mar; 61(5):1970-5. PubMed ID: 11280754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.